Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

NCT07010692 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Keratinocyte Carcinoma
Basal Cell Carcinomas
Squamous Cell Carcinoma
Skin Cancer

Interventions

DRUG: Tirbanibulin ointment 1%
DEVICE: non-ablative fractional laser

Sponsor

Bruce Robinson, MD